Appointment of Dr. Michael Sebag to CATALIS Québec’s Board
CATALIS Québec is pleased to announce that Dr. Michael Sebag will be joining its Board of Directors as of June 18, 2020. A researcher at the McGill University Health Centre (MUHC) since 2009, Dr. Sebag has participated in an impressive number of clinical studies which provided access to innovative treatments to a multitude of patients.
“With his extensive research experience, Dr. Sebag will be able to advise CATALIS Québec on the best ways to improve current practices and Québec’s positioning as a leader in the field,” said Dr. Marc Rivière, Chairman of CATALIS Québec’s Board of Directors. He then added: “We are delighted to welcome Dr. Sebag to our organization.”
“I am excited to be on the Board of Directors of CATALIS Québec, and I am looking forward to contributing to improving procedures and increasing the number of clinical trials being initiated in Quebec. That way, more patients will be able to take advantage of the benefits provided by clinical research,” said Dr. Sebag.
About CATALIS Québec
CATALIS Québec is a non-profit organization dedicated to the advancement and operational excellence of clinical research in Quebec. Our mission is to optimize Quebec’s clinical research environment to maximize private investment and accelerate the development of innovative patient care.
